Thursday, September 21, 2017 9:00:20 AM
Confident for different reasons though. I just think this company put in the hard work to get the science right. Many big pharma companies enter into trials with weak rationales in hopes of a payday. I would image many small biotechs do the same - I just can't speak to the later from my experience.
What you are saying about facilities, Lee family, skipping Ph2B rGBM, direct to Ph3 Ovarian collectively improve the confidence of many here on this forum that VB111 will be successful. We have discussed them ad nauseum. However, assuming those all point to good outcome could be a logical fallacy.
From a recent example: Juno started to build a manufacturing facility in preparation for approval in Feb 2015. Their pivotal trial JCAR015 got placed on clinical hold in July 2016 and eventually canceled in Nov 2016.
(http://www.fiercebiotech.com/r-d/juno-takes-manufacturing-plunge-a-high-stakes-car-t-race)
(http://ir.junotherapeutics.com/phoenix.zhtml?c=253828&p=irol-newsArticle&ID=2225491)
That said, I really do think that VB-111 will be a great success and I am very excited to hear the results!
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM